Abstract:Diet and the gut microbiota have a profound influence on physiology and health, however, mechanisms are still emerging. Here we outline several pathways that gut microbiota products, particularly short-chain fatty acids (SCFAs), use to maintain gut and immune homeostasis. Dietary fibre is fermented by the gut microbiota in the colon, and large quantities of SCFAs such as acetate, propionate, and butyrate are produced. Dietary fibre and SCFAs enhance epithelial integrity and thereby limit systemic endotoxemia. Moreover, SCFAs inhibit histone deacetylases (HDAC), and thereby affect gene transcription. SCFAs also bind to 'metabolite-sensing' G-protein coupled receptors (GPCRs) such as GPR43, which promotes immune homeostasis. The enormous amounts of SCFAs produced in the colon are sufficient to lower pH, which affects the function of proton sensors such as GPR65 expressed on the gut epithelium and immune cells. GPR65 is an anti-inflammatory Gαs-coupled receptor, which leads to the inhibition of inflammatory cytokines. The importance of GPR65 in inflammatory diseases is underscored by genetics associated with the missense variant I231L (rs3742704), which is associated with human inflammatory bowel disease, atopic dermatitis, and asthma. There is enormous scope to manipulate these pathways using specialized diets that release very high amounts of specific SCFAs in the gut, and we believe that therapies that rely on chemically modified foods is a promising approach. Such an approach includes high SCFA-producing diets, which we have shown to decrease numerous inflammatory western diseases in mouse models. These diets operate at many levels - increased gut integrity, changes to the gut microbiome, and promotion of immune homeostasis, which represents a new and highly promising way to prevent or treat human disease.

Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine

Dietary fatty acids and susceptibility to multiple sclerosis

Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Lactobacillaceae differentially impact butyrate-producing gut microbiota to drive CNS autoimmunity

Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation

Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells

High fat low carbohydrate diet is linked to protection against CNS autoimmunity

Impact of a high fibre diet on immune cells and the multiple sclerosis animal model

Short chain fatty acids, a possible treatment option for autoimmune diseases

Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy

A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity

Short-chain fatty acids: linking diet, the microbiome and immunity

IL-17 controls central nervous system autoimmunity through the intestinal microbiome

Short-chain fatty acids suppresses astrocyte activation by amplifying Trp-AhR-AQP4 signaling in experimental autoimmune encephalomyelitis mice

Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status

Regulation of short-chain fatty acids in the immune system

Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity

A major mechanism for immunomodulation: Dietary fibres and acid metabolites

A Potential New Therapeutic Approach

The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis